The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prothrombin Complex Concentrate Injection Market Research Report 2024
Synopsis
Factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
The global Prothrombin Complex Concentrate Injection market was valued at US$ 938 million in 2023 and is anticipated to reach US$ 2076 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.
North American market for Prothrombin Complex Concentrate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prothrombin Complex Concentrate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prothrombin Complex Concentrate Injection include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate Injection.
The Prothrombin Complex Concentrate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Prothrombin Complex Concentrate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prothrombin Complex Concentrate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prothrombin Complex Concentrate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prothrombin Complex Concentrate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
The global Prothrombin Complex Concentrate Injection market was valued at US$ 938 million in 2023 and is anticipated to reach US$ 2076 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.
North American market for Prothrombin Complex Concentrate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prothrombin Complex Concentrate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prothrombin Complex Concentrate Injection include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate Injection.
The Prothrombin Complex Concentrate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Prothrombin Complex Concentrate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prothrombin Complex Concentrate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prothrombin Complex Concentrate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prothrombin Complex Concentrate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prothrombin Complex Concentrate Injection Market Overview
1.1 Product Definition
1.2 Prothrombin Complex Concentrate Injection by Type
1.2.1 Global Prothrombin Complex Concentrate Injection Market Value Comparison by Type (2024-2030)
1.2.2 Beriplex
1.2.3 Profilnine
1.2.4 Octaplex
1.2.5 Prothromplex
1.2.6 Cofact
1.2.7 Other
1.3 Prothrombin Complex Concentrate Injection by Application
1.3.1 Global Prothrombin Complex Concentrate Injection Market Value by Application (2024-2030)
1.3.2 Hemophilia B
1.3.3 Acquired Coagulation Factor Deficiency
1.4 Global Prothrombin Complex Concentrate Injection Market Size Estimates and Forecasts
1.4.1 Global Prothrombin Complex Concentrate Injection Revenue 2019-2030
1.4.2 Global Prothrombin Complex Concentrate Injection Sales 2019-2030
1.4.3 Global Prothrombin Complex Concentrate Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prothrombin Complex Concentrate Injection Market Competition by Manufacturers
2.1 Global Prothrombin Complex Concentrate Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prothrombin Complex Concentrate Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prothrombin Complex Concentrate Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Prothrombin Complex Concentrate Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prothrombin Complex Concentrate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prothrombin Complex Concentrate Injection, Product Type & Application
2.7 Global Key Manufacturers of Prothrombin Complex Concentrate Injection, Date of Enter into This Industry
2.8 Global Prothrombin Complex Concentrate Injection Market Competitive Situation and Trends
2.8.1 Global Prothrombin Complex Concentrate Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prothrombin Complex Concentrate Injection Players Market Share by Revenue
2.8.3 Global Prothrombin Complex Concentrate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prothrombin Complex Concentrate Injection Market Scenario by Region
3.1 Global Prothrombin Complex Concentrate Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prothrombin Complex Concentrate Injection Sales by Region: 2019-2030
3.2.1 Global Prothrombin Complex Concentrate Injection Sales by Region: 2019-2024
3.2.2 Global Prothrombin Complex Concentrate Injection Sales by Region: 2025-2030
3.3 Global Prothrombin Complex Concentrate Injection Revenue by Region: 2019-2030
3.3.1 Global Prothrombin Complex Concentrate Injection Revenue by Region: 2019-2024
3.3.2 Global Prothrombin Complex Concentrate Injection Revenue by Region: 2025-2030
3.4 North America Prothrombin Complex Concentrate Injection Market Facts & Figures by Country
3.4.1 North America Prothrombin Complex Concentrate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prothrombin Complex Concentrate Injection Sales by Country (2019-2030)
3.4.3 North America Prothrombin Complex Concentrate Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prothrombin Complex Concentrate Injection Market Facts & Figures by Country
3.5.1 Europe Prothrombin Complex Concentrate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prothrombin Complex Concentrate Injection Sales by Country (2019-2030)
3.5.3 Europe Prothrombin Complex Concentrate Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prothrombin Complex Concentrate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Prothrombin Complex Concentrate Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prothrombin Complex Concentrate Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Prothrombin Complex Concentrate Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prothrombin Complex Concentrate Injection Market Facts & Figures by Country
3.7.1 Latin America Prothrombin Complex Concentrate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prothrombin Complex Concentrate Injection Sales by Country (2019-2030)
3.7.3 Latin America Prothrombin Complex Concentrate Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Prothrombin Complex Concentrate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Prothrombin Complex Concentrate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prothrombin Complex Concentrate Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prothrombin Complex Concentrate Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prothrombin Complex Concentrate Injection Sales by Type (2019-2030)
4.1.1 Global Prothrombin Complex Concentrate Injection Sales by Type (2019-2024)
4.1.2 Global Prothrombin Complex Concentrate Injection Sales by Type (2025-2030)
4.1.3 Global Prothrombin Complex Concentrate Injection Sales Market Share by Type (2019-2030)
4.2 Global Prothrombin Complex Concentrate Injection Revenue by Type (2019-2030)
4.2.1 Global Prothrombin Complex Concentrate Injection Revenue by Type (2019-2024)
4.2.2 Global Prothrombin Complex Concentrate Injection Revenue by Type (2025-2030)
4.2.3 Global Prothrombin Complex Concentrate Injection Revenue Market Share by Type (2019-2030)
4.3 Global Prothrombin Complex Concentrate Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prothrombin Complex Concentrate Injection Sales by Application (2019-2030)
5.1.1 Global Prothrombin Complex Concentrate Injection Sales by Application (2019-2024)
5.1.2 Global Prothrombin Complex Concentrate Injection Sales by Application (2025-2030)
5.1.3 Global Prothrombin Complex Concentrate Injection Sales Market Share by Application (2019-2030)
5.2 Global Prothrombin Complex Concentrate Injection Revenue by Application (2019-2030)
5.2.1 Global Prothrombin Complex Concentrate Injection Revenue by Application (2019-2024)
5.2.2 Global Prothrombin Complex Concentrate Injection Revenue by Application (2025-2030)
5.2.3 Global Prothrombin Complex Concentrate Injection Revenue Market Share by Application (2019-2030)
5.3 Global Prothrombin Complex Concentrate Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Prothrombin Complex Concentrate Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring Prothrombin Complex Concentrate Injection Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Prothrombin Complex Concentrate Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Prothrombin Complex Concentrate Injection Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Octapharma
6.3.1 Octapharma Company Information
6.3.2 Octapharma Description and Business Overview
6.3.3 Octapharma Prothrombin Complex Concentrate Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Octapharma Prothrombin Complex Concentrate Injection Product Portfolio
6.3.5 Octapharma Recent Developments/Updates
6.4 Prothya Biosolutions
6.4.1 Prothya Biosolutions Company Information
6.4.2 Prothya Biosolutions Description and Business Overview
6.4.3 Prothya Biosolutions Prothrombin Complex Concentrate Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prothya Biosolutions Prothrombin Complex Concentrate Injection Product Portfolio
6.4.5 Prothya Biosolutions Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Company Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Prothrombin Complex Concentrate Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Takeda Prothrombin Complex Concentrate Injection Product Portfolio
6.5.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prothrombin Complex Concentrate Injection Industry Chain Analysis
7.2 Prothrombin Complex Concentrate Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prothrombin Complex Concentrate Injection Production Mode & Process
7.4 Prothrombin Complex Concentrate Injection Sales and Marketing
7.4.1 Prothrombin Complex Concentrate Injection Sales Channels
7.4.2 Prothrombin Complex Concentrate Injection Distributors
7.5 Prothrombin Complex Concentrate Injection Customers
8 Prothrombin Complex Concentrate Injection Market Dynamics
8.1 Prothrombin Complex Concentrate Injection Industry Trends
8.2 Prothrombin Complex Concentrate Injection Market Drivers
8.3 Prothrombin Complex Concentrate Injection Market Challenges
8.4 Prothrombin Complex Concentrate Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Prothrombin Complex Concentrate Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Prothrombin Complex Concentrate Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Prothrombin Complex Concentrate Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Prothrombin Complex Concentrate Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Prothrombin Complex Concentrate Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Prothrombin Complex Concentrate Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Prothrombin Complex Concentrate Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Prothrombin Complex Concentrate Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Prothrombin Complex Concentrate Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Prothrombin Complex Concentrate Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prothrombin Complex Concentrate Injection, Product Type & Application
Table 12. Global Key Manufacturers of Prothrombin Complex Concentrate Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prothrombin Complex Concentrate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prothrombin Complex Concentrate Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Prothrombin Complex Concentrate Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Prothrombin Complex Concentrate Injection Sales Market Share by Region (2019-2024)
Table 19. Global Prothrombin Complex Concentrate Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Prothrombin Complex Concentrate Injection Sales Market Share by Region (2025-2030)
Table 21. Global Prothrombin Complex Concentrate Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Prothrombin Complex Concentrate Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Prothrombin Complex Concentrate Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Prothrombin Complex Concentrate Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Prothrombin Complex Concentrate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Prothrombin Complex Concentrate Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Prothrombin Complex Concentrate Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Prothrombin Complex Concentrate Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Prothrombin Complex Concentrate Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Prothrombin Complex Concentrate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Prothrombin Complex Concentrate Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Prothrombin Complex Concentrate Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Prothrombin Complex Concentrate Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Prothrombin Complex Concentrate Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Prothrombin Complex Concentrate Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Prothrombin Complex Concentrate Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Prothrombin Complex Concentrate Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Prothrombin Complex Concentrate Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Prothrombin Complex Concentrate Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Prothrombin Complex Concentrate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Prothrombin Complex Concentrate Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Prothrombin Complex Concentrate Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Prothrombin Complex Concentrate Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Prothrombin Complex Concentrate Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Prothrombin Complex Concentrate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Prothrombin Complex Concentrate Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Prothrombin Complex Concentrate Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Prothrombin Complex Concentrate Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Prothrombin Complex Concentrate Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Prothrombin Complex Concentrate Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Prothrombin Complex Concentrate Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Prothrombin Complex Concentrate Injection Sales Market Share by Type (2019-2024)
Table 53. Global Prothrombin Complex Concentrate Injection Sales Market Share by Type (2025-2030)
Table 54. Global Prothrombin Complex Concentrate Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Prothrombin Complex Concentrate Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Prothrombin Complex Concentrate Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Prothrombin Complex Concentrate Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Prothrombin Complex Concentrate Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Prothrombin Complex Concentrate Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Prothrombin Complex Concentrate Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Prothrombin Complex Concentrate Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Prothrombin Complex Concentrate Injection Sales Market Share by Application (2019-2024)
Table 63. Global Prothrombin Complex Concentrate Injection Sales Market Share by Application (2025-2030)
Table 64. Global Prothrombin Complex Concentrate Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Prothrombin Complex Concentrate Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Prothrombin Complex Concentrate Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Prothrombin Complex Concentrate Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Prothrombin Complex Concentrate Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Prothrombin Complex Concentrate Injection Price (US$/Unit) by Application (2025-2030)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Prothrombin Complex Concentrate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. CSL Behring Prothrombin Complex Concentrate Injection Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Prothrombin Complex Concentrate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Grifols Prothrombin Complex Concentrate Injection Product
Table 79. Grifols Recent Developments/Updates
Table 80. Octapharma Company Information
Table 81. Octapharma Description and Business Overview
Table 82. Octapharma Prothrombin Complex Concentrate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Octapharma Prothrombin Complex Concentrate Injection Product
Table 84. Octapharma Recent Developments/Updates
Table 85. Prothya Biosolutions Company Information
Table 86. Prothya Biosolutions Description and Business Overview
Table 87. Prothya Biosolutions Prothrombin Complex Concentrate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Prothya Biosolutions Prothrombin Complex Concentrate Injection Product
Table 89. Prothya Biosolutions Recent Developments/Updates
Table 90. Takeda Company Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Prothrombin Complex Concentrate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Takeda Prothrombin Complex Concentrate Injection Product
Table 94. Takeda Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Prothrombin Complex Concentrate Injection Distributors List
Table 98. Prothrombin Complex Concentrate Injection Customers List
Table 99. Prothrombin Complex Concentrate Injection Market Trends
Table 100. Prothrombin Complex Concentrate Injection Market Drivers
Table 101. Prothrombin Complex Concentrate Injection Market Challenges
Table 102. Prothrombin Complex Concentrate Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Prothrombin Complex Concentrate Injection
Figure 2. Global Prothrombin Complex Concentrate Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Prothrombin Complex Concentrate Injection Market Share by Type: 2023 & 2030
Figure 4. Beriplex Product Picture
Figure 5. Profilnine Product Picture
Figure 6. Octaplex Product Picture
Figure 7. Prothromplex Product Picture
Figure 8. Cofact Product Picture
Figure 9. Other Product Picture
Figure 10. Global Prothrombin Complex Concentrate Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 11. Global Prothrombin Complex Concentrate Injection Market Share by Application: 2023 & 2030
Figure 12. Hemophilia B
Figure 13. Acquired Coagulation Factor Deficiency
Figure 14. Global Prothrombin Complex Concentrate Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Prothrombin Complex Concentrate Injection Market Size (2019-2030) & (US$ Million)
Figure 16. Global Prothrombin Complex Concentrate Injection Sales (2019-2030) & (K Units)
Figure 17. Global Prothrombin Complex Concentrate Injection Average Price (US$/Unit) & (2019-2030)
Figure 18. Prothrombin Complex Concentrate Injection Report Years Considered
Figure 19. Prothrombin Complex Concentrate Injection Sales Share by Manufacturers in 2023
Figure 20. Global Prothrombin Complex Concentrate Injection Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Prothrombin Complex Concentrate Injection Players: Market Share by Revenue in Prothrombin Complex Concentrate Injection in 2023
Figure 22. Prothrombin Complex Concentrate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Prothrombin Complex Concentrate Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Prothrombin Complex Concentrate Injection Sales Market Share by Country (2019-2030)
Figure 25. North America Prothrombin Complex Concentrate Injection Revenue Market Share by Country (2019-2030)
Figure 26. United States Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Prothrombin Complex Concentrate Injection Sales Market Share by Country (2019-2030)
Figure 29. Europe Prothrombin Complex Concentrate Injection Revenue Market Share by Country (2019-2030)
Figure 30. Germany Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Prothrombin Complex Concentrate Injection Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Prothrombin Complex Concentrate Injection Revenue Market Share by Region (2019-2030)
Figure 37. China Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Prothrombin Complex Concentrate Injection Sales Market Share by Country (2019-2030)
Figure 45. Mexico Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Prothrombin Complex Concentrate Injection Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Prothrombin Complex Concentrate Injection Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Prothrombin Complex Concentrate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Prothrombin Complex Concentrate Injection by Type (2019-2030)
Figure 55. Global Revenue Market Share of Prothrombin Complex Concentrate Injection by Type (2019-2030)
Figure 56. Global Prothrombin Complex Concentrate Injection Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Prothrombin Complex Concentrate Injection by Application (2019-2030)
Figure 58. Global Revenue Market Share of Prothrombin Complex Concentrate Injection by Application (2019-2030)
Figure 59. Global Prothrombin Complex Concentrate Injection Price (US$/Unit) by Application (2019-2030)
Figure 60. Prothrombin Complex Concentrate Injection Value Chain
Figure 61. Prothrombin Complex Concentrate Injection Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
